Pacific AETC Nevada’s E-Learning

Demystifying Latent Tuberculosis Infections and Treatment for the Primary Care Provider

Neda Etezadi-Amoli MD and Cherie Singer PhD, discuss strategies for identifying and addressing professionalism issues, using case studies to illustrate key points. In this session, you'll gain valuable insights on creating a more supportive atmosphere for medical students you interact with.

Provides 0.75 hours of CE/CME credit.

Learning Objectives

Following participation in this activity, participants should be able to:

• Explain why identification and treatment of latent TB infection (LTBI) is key to eliminating TB disease

• Explain the impact of LTBI on persons with HIV and the essential components of an individual TB Risk Assessment Tool

• Explain the advantages and disadvantages of TB blood tests, IGRAs.

• Describe other diagnostics necessary to distinguish LTBI from active TB disease given that TB skin tests (TST) or TB blood tests (IGRAs) cannot rule-out active tuberculosis disease.

• Discuss the current recommended short-course treatments for LTBI and the advantages versus disadvantages, to inform appropriate use in clinical practice

Presenters

Janice Louie, MD, MPH is Medical Director of the San Francisco Department of Public Health Tuberculosis Prevention and Control Program, and Assistant Clinical Professor in the University of California San Francisco Department of Medicine. Her primary focus is to ensure continued excellence in the clinical management of tuberculosis, provide mentorship and training to fellows, residents, and other trainees, and advancing clinical practices in tuberculosis with a focus on the elderly.
 
Susan McElhany, DMD, is the Tuberculosis Program Manager for the Office of State Epidemiology, within the Nevada Division of Public and Behavioral Health, Department of Health and Human Services.

Online Registration for Demystifying Latent Tuberculosis Infections and Treatment for the Primary Care Provider

Congenital Syphilis

This required training introduces faculty and staff to the Family Educational Rights and Privacy Act (FERPA), outlining responsibilities for safeguarding student records and ensuring compliance with federal privacy requirements.

Provides 1.00 hour of CE/CME credit.

Learning Objectives

Following participation in this course, participants should be able to:

• Describe congenital syphilis epidemiology
• Discuss screening updates and POT screening
• Explain the pathophysiology, manifestations, and treatment for congenital syphilis

Presenters

Rosalyn Plotzker, M.D., MPH, Assistant Professor | UCSF Dept. of Epidemiology and Biostatistics | Clinical Faculty| California Prevention Training Center | Provider | UCSF Anal Neoplasia, Clinic, Research and Education (ANCRE) Center | Public Health Medical Officer| CDPH STD Control Branch

Elizabeth Kessler, MPH
OPHIE Surveillance Manager | Office of Public Health Investigations and Epidemiology | Division of Public and Behavioral Health | Nevada Department of Health and Human Services

Online Registration for Congenital Syphilis

 

Xylazine and HIV in the Era of Synthetic Street Drugs

Provides 1.00 hour of CE/CME credit.

Learning Objectives

Following participation in this activity, participants should be able to:

• Describe how the sudden expansion of xylazine, fentanyl, and crystal methamphetamine use is related to the history of US drug markets since 1990
• Describe how each of these substances relate to one another in the experience of consumption and in their public health impact, including on HIV and drug overdose risk
• Examine avenues for novel public health interventions to minimize the risk of HIV, drug overdose, and related comorbidities, as well as to regulate drug markets to make them less toxic and less economically exploitative for both people who use drugs and people who sell them

Presenter

Fernando Montero, Ph.D., Chief T32 Postdoctoral Research Fellow, HIV Center for Clinical and Behavioral Studies, Department of Psychiatry, Columbia University

Online Registration for Xylazine and HIV in the Era of Synthetic Street Drugs